Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Russo
Dr. Paul Russo is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 47 years. He is one of 87 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Cancer Biology, 1986 - 1988- Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1984 - 1988
Washington University/B-JH/SLCH ConsortiumResidency, Urology, 1981 - 1984- Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1979 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979
Certifications & Licensure
NJ State Medical License 2021 - 2027
NY State Medical License 1988 - 2027
CT State Medical License 2023 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016-2017
- CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016-2017
- New York City Best Doctors Castle Connelly, 2000-2016
Clinical Trials
- Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. Start of enrollment: 2005 Jun 01
Publications & Presentations
PubMed
- Hypoxia shapes both therapeutic response and resistance in metastatic clear cell renal cell carcinoma.Lynda Vuong, Andrew E Cornish, Jennifer Pfeil, Yash Khandwala, Hui Jiang
Cancer Cell. 2026-06-04 - Clinical Management of Synchronous and Metachronous Renal Lesions in Patients With Oncocytoma Treated With Nephrectomy: A 30-Year Single-Center Experience.Lennert Eismann, Stephen W Reese, Mark T Dawidek, Lina Posada Calderon, Andreas Aulitzky
Clinical Genitourinary Cancer. 2026-02-01 - 1 citationsPathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma.Yash S Khandwala, Stephen W Reese, Burcin A Ucpinar, Andrea Knezevic, Lennert Eismann
European Urology Oncology. 2026-02-01
Journal Articles
- Importance of Wide Re‐Resection in Adult Spermatic Cord Sarcomas: Report on Oncologic Outcomes at a Single InstitutionMassimiliano Spaliviero, Kaled M Alektiar, Harry W Herr, Paul Russo, Journal of Surgical Oncology
- Analysis of Renal Cancer Cell Lines from Two Major Resources Enables Genomics-Guided Cell Line SelectionSatish K Tickoo, Paul Russo, A Ari Hakimi, Victor E Reuter, James J Hsieh, Jonathan A Coleman, Michael Chevinsky, Christopher Jakubowski, Andrew G Winer, Nature
Authored Content
- Minerva Urologica E Nefrologica 2017 December;69(6):539-47August 2018
Press Mentions
Study Shows No Link Between Race and Mortality in Clear Cell RCCDecember 17th, 2020- PN Risks May Outweigh Benefits in Some CKD CasesSeptember 3rd, 2020
Does Cytoreductive Nephrectomy Remain an Essential Component of Care for Advanced Renal Cell Carcinoma?June 25th, 2019
Professional Memberships
- Member
- Member
- Member
- Member
- Society of Urological OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
